Tianjin Ringpu Bio-technology Co., Ltd. (300119) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tianjin Ringpu Bio-technology Co., Ltd.

Why is Tianjin Ringpu Bio-technology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 15.26% and Operating profit at 5.92% over the last 5 years

Positive results in Sep 25

OPERATING CASH FLOW(Y) Highest at CNY 680.87 MM
NET SALES(9M) At CNY 2,538.49 MM has Grown at 21.45%
NET PROFIT(HY) At CNY 229.77 MM has Grown at 56.32%

With ROE of 9.27%, it has a fair valuation with a 2.13 Price to Book Value

Over the past year, while the stock has generated a return of -1.21%, its profits have fallen by -4.4%
At the current price, the company has a high dividend yield of 1.4

Below par performance in long term as well as near term

Along with generating -1.21% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Tianjin Ringpu Bio-technology Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tianjin Ringpu Bio-technology Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Tianjin Ringpu Bio-technology Co., Ltd.

1.79%

0.45

40.74%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.26%

EBIT Growth (5y)

5.92%

EBIT to Interest (avg)

14.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.04

Sales to Capital Employed (avg)

0.47

Tax Ratio

10.67%

Dividend Payout Ratio

46.48%

Pledged Shares

Institutional Holding

ROCE (avg)

11.09%

ROE (avg)

9.50%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.13

EV to EBIT

22.12

EV to EBITDA

14.65

EV to Capital Employed

2.14

EV to Sales

2.66

PEG Ratio

Dividend Yield

1.44%

ROCE (Latest)

9.67%

ROE (Latest)

9.27%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 680.87 MM

NET SALES(9M)

At CNY 2,538.49 MM has Grown at 21.45%

NET PROFIT(HY)

At CNY 229.77 MM has Grown at 56.32%

INVENTORY TURNOVER RATIO(HY)

Highest at 5.5 times

DEBTORS TURNOVER RATIO(HY)

Highest at 3.32 times

-12What is not working for the Company

INTEREST(HY)

At CNY 18.04 MM has Grown at 11.46%

NET SALES(Q)

At CNY 836.74 MM has Fallen at -12.84%

INTEREST COVERAGE RATIO(Q)

Lowest at 1,186.07

DEBT-EQUITY RATIO (HY)

Highest at -4.03 %

OPERATING PROFIT(Q)

Lowest at CNY 105.02 MM

Here's what is working for Tianjin Ringpu Bio-technology Co., Ltd.

Operating Cash Flow

Highest at CNY 680.87 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Profit

At CNY 229.77 MM has Grown at 56.32%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Inventory Turnover Ratio

Highest at 5.5 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 3.32 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Tianjin Ringpu Bio-technology Co., Ltd.

Interest

At CNY 18.04 MM has Grown at 11.46%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

At CNY 836.74 MM has Fallen at -12.84%

over average net sales of the previous four periods of CNY 960.05 MM

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Interest Coverage Ratio

Lowest at 1,186.07

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at CNY 105.02 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Debt-Equity Ratio

Highest at -4.03 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio